< Back to previous page
Researcher
Peter Carmeliet
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Cell death, Cancer biology
- Disciplines (KU Leuven):Cardiac and vascular medicine
- See also: Peter Carmeliet (Flanders Institute for Biotechnology)
Affiliations
- Laboratory of Angiogenesis and Vascular Metabolism (VIB-KU Leuven) (Division)
Responsible
From1 Jan 2012 → Today - Carmeliet Lab (Research group)
Responsible
From1 Jan 2017 → Today - Laboratory of Angiogenesis and Vascular Metabolism (VIB-KU Leuven) (Division)
Member
From1 Jan 2012 → Today - Centre for Molecular and Vascular Biology (Division)
Member
From1 Oct 1999 → 30 Sep 2005
Projects
1 - 10 of 110
- Angiogenesis and Vascular HeterogeneityFrom9 Jan 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Immunomodulatory role of graft endothelial cells to improve organ transplantationFrom30 Nov 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Demystifying the mystery genome for alternative immunotherapy targets: combining artificial intelligence-based discovery of immunomodulatory endothelial cell targets and in vivo target validation.From1 Oct 2022 → 30 Sep 2023Funding: BOF - postdoctoral mandates
- DEMYSTIFYING ALTERNATIVE IMMUNOTHERAPY MYSTERY TARGETS BY COMBINING ARTIFICIAL INTELLIGENCE- BASED TARGET DISCOVERY AND LARGER-SCALE TARGET VALIDATIONFrom1 Oct 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Immunomodulatory endothelial cells (IMECs): dissecting their immunosuppressive / im- munostimulatory features via nanoparticle-based gene silencing or overexpressionFrom26 Sep 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Validating novel AI-predicted targets for alternative cancer immunotherapyFrom20 Sep 2022 → TodayFunding: FWO fellowships, Foundations, funds and other with scientific goal
- Angiogenesis and Vascular HeterogeneityFrom19 Sep 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Metabolic and epigenetic interplay in neural progenitor cells: investigating neurodevelopmental disorders associated with impaired neural progenitor cell expansion (MEPIcephaly).From1 Jun 2022 → TodayFunding: FWO research project (including WEAVE projects)
- Imaging the invisible in preclinical models using magnetic particle imagingFrom1 May 2022 → TodayFunding: FWO Large scale research infrastructure
- Next-generation, multi-technology immune-monitoring and easy-access spectral flow cytometryFrom1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
Publications
511 - 520 of 587
- Plasminogen Activator Inhibitor-1 Regulates Integrin alpha v beta 3 Expression and Autocrine Transforming Growth Factor beta Signaling(2009)
Authors: Peter Carmeliet
Pages: 20708 - 20717 - G Protein-Coupled Receptor APJ and Its Ligand Apelin Act Downstream of Cripto to Specify Embryonic Stem Cells Toward the Cardiac Lineage Through Extracellular Signal-Regulated Kinase/p70S6 Kinase Signaling Pathway(2009)
Authors: Peter Carmeliet
Pages: 231 - Endothelial oxygen sensors regulate tumor vessel abnormalization by instructing phalanx endothelial cells(2009)
Authors: Katrien De Bock, Frederik De Smet, Rodrigo Leite-de-Oliveira, Peter Carmeliet
Pages: 561 - 569 - "Antimyeloangiogenic" therapy for cancer by inhibiting PlGF(2009)
Authors: Peter Carmeliet
Pages: 3648 - 3653 - Branching morphogenesis and antiangiogenesis candidates: tip cells lead the way(2009)
Authors: Peter Carmeliet, Frederik De Smet, Max Mazzone
Pages: 315 - 326 - Genetic Approaches in ALS: From Small Animal Models to Human Disease(2009)
Authors: Wim Robberecht, Ludo Van Den Bosch, Peter Carmeliet
- Mechanisms of vessel branching: filopodia on endothelial tip cells lead the way(2009)
Authors: Frederik De Smet, Inmaculada Segura-Vitutia, Katrien De Bock, Peter Carmeliet
Pages: 639 - 649 - Role and Therapeutic Potential of VEGF in the Nervous System(2009)
Authors: Diether Lambrechts, Max Mazzone, Peter Carmeliet
Pages: 607 - 648 - Hypoxia induces dilated cardiomyopathy in the chick embryo: mechanism, intervention, and long-term consequences(2009)
Authors: Peter Carmeliet, Marc Tjwa
- Membrane-anchored uPAR regulates the proliferation, marrow pool size, engraftment, and mobilization of mouse hematopoietic stem/progenitor cells(2009)
Authors: Marc Tjwa, Mieke Dewerchin, Lieve Moons, Catherine Verfaillie, Peter Carmeliet
Pages: 1008 - 1018
Patents
1 - 10 of 10
- Carnitine palmitoyltransferase 1 inhibitors for inhibition of pathological angiogenesis (Inventor)
- Extracellular allosteric inhibitor binding domain from a tyrosine kinase receptor (Inventor)
- Inhibition of plgf to treat philadelphia chromosome positive leukemia (Inventor)
- Means and methods for treating lung hypoplasia (Inventor)
- Use of VEGF and homologues to treat neuron disorders (Inventor)
- Novel anti-PLGF antibody (Inventor)
- Anti-angiogenic therapy (Inventor)
- Responsiveness to angiogenesis inhibitors (Inventor)
- CARNITINE PALMITOYLTRANSFERASE 1 INHIBITORS FOR INHIBITION OF PATHOLOGICAL ANGIOGENESIS (Inventor)
- GLUTAMINE SYNTHETASE INHIBITORS FOR INHIBITION OF PATHOLOGICAL ANGIOGENESIS (Inventor)